Congress of neurological surgeons systematic review and evidence-based guidelines update on the role of cytoreductive surgery in the management of progressive glioblastoma in adults

[1]  T. Burns,et al.  Laser Interstitial Thermal Therapy for Recurrent Glioblastoma: Pooled Analyses of Available Literature. , 2021, World neurosurgery.

[2]  A. Korshoej,et al.  Comparison of 5-aminolevulinic acid and sodium fluorescein for intraoperative tumor visualization in patients with high-grade gliomas: a single-center retrospective study. , 2020, Journal of neurosurgery.

[3]  Clark C. Chen,et al.  Photodynamic Therapy for the Treatment of Glioblastoma , 2020, Frontiers in Surgery.

[4]  P. Ferroli,et al.  Fluorescein Sodium in the Surgical Treatment of Recurrent Glioblastoma Multiforme. , 2019, World neurosurgery.

[5]  J. Pallud,et al.  A Meta-Analysis of Survival Outcomes Following Reoperation in Recurrent Glioblastoma: Time to Consider the Timing of Reoperation , 2019, Front. Neurol..

[6]  V. Seifert,et al.  Impact of resection on overall survival of recurrent Glioblastoma in elderly patients , 2018, Clinical Neurology and Neurosurgery.

[7]  M. Berger,et al.  5-Aminolevulinic acid fluorescence guided surgery for recurrent high-grade gliomas , 2018, Journal of Neuro-Oncology.

[8]  C. Wirtz,et al.  Is MGMT promoter methylation to be considered in the decision making for recurrent surgery in glioblastoma patients? , 2018, Clinical Neurology and Neurosurgery.

[9]  S. Vleeschouwer,et al.  Recurring Glioblastoma: A Case for Reoperation? , 2017 .

[10]  P. Perrini,et al.  Second surgery for recurrent glioblastoma: A concise overview of the current literature , 2016, Clinical neurology and neurosurgery (Dutch-Flemish ed. Print).

[11]  A. Brandes,et al.  Patient outcomes following second surgery for recurrent glioblastoma. , 2016, Future oncology.

[12]  V. Seifert,et al.  Combination of 5-ALA and iMRI in re-resection of recurrent glioblastoma , 2016, British journal of neurosurgery.

[13]  G. Reifenberger,et al.  Complete resection of contrast-enhancing tumor volume is associated with improved survival in recurrent glioblastoma-results from the DIRECTOR trial. , 2015, Neuro-oncology.

[14]  B. Meyer,et al.  Clinical benefit from resection of recurrent glioblastomas: results of a multicenter study including 503 patients with recurrent glioblastomas undergoing surgical resection. , 2016, Neuro-oncology.

[15]  G. Mckhann,et al.  The Safety of Surgery in Elderly Patients with Primary and Recurrent Glioblastoma. , 2015, World neurosurgery.

[16]  N. Zamboglou,et al.  Salvage therapy for recurrent glioblastoma multiforme: a multimodal approach combining fluorescence-guided resurgery, interstitial irradiation, and chemotherapy , 2014, Neurological research.

[17]  K. Zaghloul,et al.  Residual tumor volume and patient survival following reoperation for recurrent glioblastoma. , 2014, Journal of neurosurgery.

[18]  Peter Nakaji,et al.  An extent of resection threshold for recurrent glioblastoma and its risk for neurological morbidity. , 2014, Journal of neurosurgery.

[19]  J. Olson,et al.  The role of cytoreductive surgery in the management of progressive glioblastoma , 2014, Journal of Neuro-Oncology.

[20]  H. Seol,et al.  A practical scoring system to determine whether to proceed with surgical resection in recurrent glioblastoma. , 2013, Neuro-oncology.

[21]  Mitchel S Berger,et al.  Impact of extent of resection for recurrent glioblastoma on overall survival: clinical article. , 2012, Journal of neurosurgery.

[22]  Mitchel S Berger,et al.  An extent of resection threshold for newly diagnosed glioblastomas. , 2011, Journal of neurosurgery.

[23]  Jörg-Christian Tonn,et al.  Counterbalancing risks and gains from extended resections in malignant glioma surgery: a supplemental analysis from the randomized 5-aminolevulinic acid glioma resection study. Clinical article. , 2011, Journal of neurosurgery.

[24]  Neurochirurgische Klinik,et al.  Counterbalancing risks and gains from extended resections in malignant glioma surgery: a supplemental analysis from the randomized 5-aminolevulinic acid glioma resection study , 2011 .

[25]  P. Black,et al.  Scale to predict survival after surgery for recurrent glioblastoma multiforme. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  Arya Nabavi,et al.  FIVE‐AMINOLEVULINIC ACID FOR FLUORESCENCE‐GUIDED RESECTION OF RECURRENT MALIGNANT GLIOMAS: A PHASE II STUDY , 2009, Neurosurgery.

[27]  A. Kaufmann,et al.  Glioblastoma , 2006, Neurology.